All NTLA Stock Tumbles 9% as Intellia Bets $180 Million on Its CRISPR FutureBy Jack WardApril 29, 20260 The way Intellia Therapeutics has been appearing on traders’ screens lately has an almost theatrical quality. NTLA opened at $12.14…
